Groupama Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.8M | Buy |
660,957
+91,746
| +16% | +$3.72M | 0.44% | 49 |
|
|
2025
Q1 | $18.2M | Buy |
569,211
+52,020
| +10% | +$1.67M | 0.36% | 58 |
|
|
2024
Q4 | $18.6M | Buy |
517,191
+101,131
| +24% | +$3.63M | 0.38% | 56 |
|
|
2024
Q3 | $13.8M | Buy |
416,060
+36,084
| +9% | +$1.2M | 0.36% | 57 |
|
|
2024
Q2 | $18.1M | Buy |
379,976
+122,108
| +47% | +$5.82M | 0.25% | 72 |
|
|
2024
Q1 | $17M | Sell |
257,868
-99,168
| -28% | -$6.55M | 0.31% | 67 |
|
|
2023
Q4 | $18.1M | Buy |
+357,036
| New | +$18.1M | 0.47% | 46 |
|